Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇰🇷KR · Science#1411K to 10K
- 🇧🇷BR · Science#1821K to 10K
- 🇦🇪AE · Science#107500 to 3K
- 🇮🇱IL · Science#171500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 13K🎙 Weekly cadence·34 episodes·Last published 4d ago - Monthly Reach
Unique listeners across all episodes (30 days)
3K to 26K🇰🇷38%🇧🇷38%🇦🇪12%+1 more - Active Followers
Loyal subscribers who consistently listen
900 to 7.8K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress
Jun 24, 2026
Unknown duration
Ovarian Cancer — Fifth Annual National General Medical Oncology Summit
Jun 19, 2026
Unknown duration
HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Jun 17, 2026
Unknown duration
Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer
Jun 3, 2026
1h 31m 15s
Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer
May 21, 2026
1h 28m 27s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 | For Oncology Nurses: Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress | Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics:Introduction: Biology of Endometrial Cancer (EC) (0:00)First-Line Therapy for Advanced or Recurrent EC (14:15)Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13)Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48)Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28)NCPD information and select publications | — | ||||||
| 6/19/26 | Ovarian Cancer — Fifth Annual National General Medical Oncology Summit | Featuring perspectives from Dr Deborah K Armstrong and Dr David M O’Malley, including the following topics: Introduction (0:00)PARP Inhibitors and Strategies Targeting Folate Receptor Alpha in Advanced Ovarian Cancer — Dr Armstrong (4:37)Other Novel Agents and Strategies for the Treatment of Advanced Ovarian Cancer — Dr O’Malley (35:18)CME information and select publications | — | ||||||
| 6/17/26 | HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer | Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley and Dr Brian M Slomovitz, moderated by Dr O’Malley, including the following topics:Introduction (0:00)Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O’Malley (1:00:31)CME information and select publications | — | ||||||
| 6/3/26 | Antibody-Drug Conjugates in Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer✨ | antibody-drug conjugatesgynecologic cancers+3 | Prof Ramez N EskanderDr Bradley J Monk+1 | UC San Diego Moores Cancer CenterFlorida Cancer Specialists & Research Institute+1 | — | antibody-drug conjugatesgynecologic oncology+3 | — | 1h 31m 15s | |
| 5/21/26 | Ovarian Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer✨ | ovarian cancerclinical trials+3 | Prof Nicoletta ColomboDr Alexander Olawaiye+2 | European Institute of Oncology IRCCSUniversity of Pittsburgh School of Medicine+2 | — | ovarian cancerclinical trials+3 | — | 1h 28m 27s | |
| 5/14/26 | Immunotherapy for Endometrial Cancer — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancer✨ | immunotherapyendometrial cancer+3 | Dr Floor J BackesDr Matthew A Powell+1 | The James Cancer Hospital and Solove Research InstituteWashington University School of Medicine+1 | Columbus, OhioSt Louis, Missouri+1 | immunotherapyendometrial cancer+5 | — | 1h 29m 32s | |
| 3/7/26 | Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances✨ | ovarian cancertherapy selection+3 | Prof Nicoletta ColomboDr Kathleen N Moore | Gynecologic Oncology Update | — | ovarian cancertherapy sequencing+3 | — | 55m 39s | |
| 2/16/26 | Gynecologic Cancers — Highlights from the 2025 ESMO Annual Meeting✨ | gynecologic cancersESMO Congress+3 | Dr Ritu Salani | David Geffen School of Medicine at UCLA | Los Angeles | gynecologic cancersESMO Congress 2025+3 | — | 57m 09s | |
| 2/9/26 | Antibody-Drug Conjugates for Ovarian Cancer — An Interview with Dr Kathleen N Moore✨ | ovarian cancerantibody-drug conjugates+3 | Dr Kathleen N Moore | Fred and Pamela Buffett Cancer Center | Omaha, Nebraska | ovarian cancerantibody-drug conjugates+4 | — | 54m 56s | |
| 12/13/25 | Ovarian Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network✨ | ovarian cancertreatment landscape+3 | Dr Gottfried E Konecny | University of California, Los AngelesAmerican Oncology Network+1 | — | ovarian cancertreatment+3 | — | 48m 48s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/7/25 | Endometrial Cancer — Clinical Investigator Perspectives on Actual Patient Cases✨ | endometrial cancertreatment strategies+3 | Dr Kathleen N MooreDr Matthew A Powell | OU Health Stephenson Cancer CenterWashington University School of Medicine | Oklahoma CitySt Louis | endometrial cancertreatment strategies+3 | — | 1h 00m 17s | |
| 8/21/25 | Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm✨ | ovarian cancerendometrial cancer+3 | Dr Shannon Westin | University of Texas MD Anderson Cancer CenterGynecologic Oncology Update | Houston | ovarian cancerendometrial cancer+3 | — | 52m 35s | |
| 8/2/25 | Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances✨ | gynecologic cancersovarian cancer+5 | Prof Susana BanerjeeDr Ursula Matulonis | The Institute of Cancer ResearchDana-Farber Cancer Institute | LondonBoston | gynecologic oncologycancer management+3 | — | 59m 34s | |
| 7/21/25 | Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches✨ | ovarian cancernursing considerations+3 | Ms Jennifer Filipi | Massachusetts General Hospital Cancer Center | Boston | ovarian cancernursing+5 | — | 53m 51s | |
| 7/1/25 | Ovarian and Endometrial Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting✨ | ovarian cancerendometrial cancer+3 | Dr Joyce F LiuDavid M O’Malley+2 | — | — | ovarian cancerendometrial cancer+5 | — | 1h 59m 45s | |
| 6/24/25 | For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress✨ | ovarian cancerclinical treatment+3 | Dr David O’MalleyDr Shannon Westin | ONS Congress | — | ovarian cancertreatment landscape+3 | — | 1h 31m 27s | |
| 6/6/25 | For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress | Dr Ritu Salani and Dr Brian Slomovitz and nurse practitioners Ms Kathryn Lyle and Ms Jaclyn Shaver discuss datasets guiding treatment decision-making for patients with endometrial cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here. | — | ||||||
| 5/11/25 | Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit | Clinical investigators discuss available data guiding the management of gynecologic cancers. CME information and select publications here. | — | ||||||
| 4/17/25 | Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️ | Dr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer. CME information and select publications here. | — | ||||||
| 4/3/25 | HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️ | Drs Kathleen N Moore and Alessandro D Santin and moderator Dr David M O’Malley summarize and share their perspectives on data guiding the management of HER2-positive gynecologic cancers that were presented at the Society of Gynecologic Oncology 2025 annual meeting. CME information and select publications here. | — | ||||||
| 12/17/24 | Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers | Dr Kathleen N Moore shares her perspectives on the evolving therapeutic landscape for patients with gynecologic cancers. | — | ||||||
| 8/22/24 | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer | Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2024 on the management of ovarian and endometrial cancers. | — | ||||||
| 7/26/24 | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology | Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers. | — | ||||||
| 2/16/24 | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series | Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer. | — | ||||||
| 1/24/24 | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series | Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer. | — | ||||||
Showing 25 of 40
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Listen to Gynecologic Oncology
Gynecologic Oncology
SGO on the GO
The Society of Gynecologic Oncology
IJGC conversations
ijgcgroup
Gastrointestinal Cancer Update
Dr. Neil Love
Ready, Set, GYO!
Ready, Set, GYO: An educational gynecologic oncology podcast
ASCO Daily News
American Society of Clinical Oncology (ASCO)
Breast Cancer Update
Dr. Neil Love
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.